MIRM – Mirum Pharmaceuticals Inc
Investors holding1
Combined shares32,129
Combined reported value$2.7M
MIRM chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.
Ownership
| Investor | % of their portfolio | Change | Shares | Reported value | Period |
|---|---|---|---|---|---|
| Polen Capital | 0.03 | Added 53.7% | 32,129 | $2.7M | Q3 2026 |
Activity: last 4 quarters
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Polen Capital | Added 53.7% | 32,129 | 0.01 |
| Q2 2026 | Polen Capital | Added 1.8% | 20,899 | 0.00 |
| Q1 2026 | Polen Capital | Added 53.7% | 20,531 | 0.00 |
| Q1 2026 | Paul Tudor Jones narrow view | Closed | 0 | 0.00 |
| Q4 2025 | Paul Tudor Jones narrow view | Reduced 81.2% | 5,205 | 0.01 |
| Q4 2025 | Polen Capital | Added 0.2% | 13,360 | 0.00 |
Added: opened or increased
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q3 2026 | Polen Capital | Added 53.7% | 32,129 | 0.01 |
| Q2 2026 | Polen Capital | Added 1.8% | 20,899 | 0.00 |
| Q1 2026 | Polen Capital | Added 53.7% | 20,531 | 0.00 |
| Q4 2025 | Polen Capital | Added 0.2% | 13,360 | 0.00 |
Reduced: reduced or closed
| Period | Investor | Change | Shares after | Effect on their portfolio (pts) |
|---|---|---|---|---|
| Q1 2026 | Paul Tudor Jones narrow view | Closed | 0 | 0.00 |
| Q4 2025 | Paul Tudor Jones narrow view | Reduced 81.2% | 5,205 | 0.01 |
History
2 peakQ3 2026: 1 tracked investors
20202026
Shares held, last 8 quarters
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Polen Capital | 32.1K | 20.9K | 20.5K | 13.4K | 13.3K | 15.5K | – | – |
– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).